H Goldschmidt
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension
Bringhen S, Ludwig H, Driessen C, Auner H, Caers J, Gramatzki M, Dimopoulos M, Boccadoro M, Einsele H, Sonneveld P, Cavo M, Goldschmidt H, Milan A, D'Agostino M, Ferri C, Wäsch R, Gay F, Larocca A, Offidani M, Zweegman S, Terpos E, Engelhardt M. Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension. J Intern Med 2019; 286:63-74.
08.04.2019Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension
08.04.2019J Intern Med 2019; 286:63-74
Bringhen S, Ludwig H, Driessen Christoph, Auner H W, Caers J, Gramatzki Martin, Dimopoulos M A, Boccadoro M, Einsele H, Sonneveld P, Cavo M, Goldschmidt H, Milan A, D'Agostino M, Ferri C, Wäsch R, Gay F, Larocca A, Offidani M, Zweegman S, Terpos E, Engelhardt M
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
Ludwig H, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk N, Waage A, Beksac M, Mellqvist U, Engelhardt M, Caers J, Driessen C, Mateos M, Garderet L, Zweegman S, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos M, San-Miguel J, Terpos E, Sonneveld P. Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network. Leukemia 2017
18.12.2017Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
18.12.2017Leukemia 2017
Ludwig H, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk N W C J, Waage A, Beksac M, Mellqvist U H, Engelhardt M, Caers J, Driessen Christoph, Mateos M-V, Garderet L, Zweegman S, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos M A, San-Miguel J F, Terpos E, Sonneveld P
Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer
Huober J, Haas R, Bastert G, Goldschmidt H, Martin S, Meyer A, Wittmann G, Hohaus S, Schneeweiss A, Wallwiener D. Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer. Journal of cancer research and clinical oncology 1998; 124:690-4.
01.01.1998Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer
01.01.1998Journal of cancer research and clinical oncology 1998; 124:690-4
Huober Jens, Haas R, Bastert G, Goldschmidt H, Martin S, Meyer A, Wittmann G, Hohaus S, Schneeweiss A, Wallwiener D